46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
70.22.Z - Head office activities and management consultancy
72.19.Z - Scientific research and development activities
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
85.60.Z - Educational support activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 27,8 | 29 | 31,8 | 9,6 |
Gross profit (loss) | 1,5 | 2 | 3,5 | 78,6 |
EBITDA | 1,8 | 2,1 | 3,7 | 78,2 |
Net profit (loss) | 1,2 | 1,5 | 2,8 | 81,6 |
Net income from sale | 49,2 | 55,8 | 66,9 | 19,9 |
Liabilities and provisions for liabilities | 23,2 | 24,1 | 25,6 | 6,3 |
Short time liabilities | 13,2 | 9,6 | 8,2 | -14,3 |
Equity capital | 4,6 | 4,9 | 6,2 | 25,5 |
Working assets | 25,7 | 26,5 | 27,5 | 3,8 |
Operating profit (EBIT) | 1,5 | 1,7 | 3,3 | 95,8 |
Depreciation | 0,3 | 0,4 | 0,4 | 1 |
% | % | % | p.p. | |
Profitability of capital | 25,7 | 31,2 | 45,1 | 13,9 |
Equity capital to total assets | 16,4 | 17 | 19,4 | 2,4 |
Gross profit margin | 3 | 3,5 | 5,2 | 1,7 |
EBITDA Margin | 3,8 | 3,7 | 5,6 | 1,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 98 | 63 | 45 | -18 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane